Fig. 2From: Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathya Acylcarnitines comparison in baseline patients with eGFR< 60 and eGFR> = 60. Five Acylcarnitines (red dotted) showed increased in patients with eGFR< 60. b The differential concentrations of five acylcarnitines in baseline patients with eGFR< 60 and eGFR> = 60Back to article page